Pirin down-regulates the EAF2/U19 protein and alleviates its growth inhibition in prostate cancer cells

Prostate

Volumn 74, Issue 2, 2014, Pages 113-120

  Wang, Zhou ^a,b,d   Qiao, Zhongjie ^a,b   Wang, Dan ^b   Hahn, Junghyun ^c   Ai, Junkui ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

EAF2 U19; Pirin; prostate cancer

Indexed keywords

CELL PROTEIN; ELL ASSOCIATED FACTOR 2; PIRIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL STRAIN LNCAP; CELLULAR DISTRIBUTION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROSTATE CANCER; WESTERN BLOTTING;

EAF2/U19; PIRIN; PROSTATE CANCER;

ADENOCARCINOMA; APOPTOSIS; CARCINOGENESIS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; HUMANS; IMMUNOPRECIPITATION; MALE; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; PROTEIN BINDING; TRANSCRIPTION FACTORS;

EID: 84891153770     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22729     Document Type: Article

References (19)

1. Wang Z, Tufts R, Haleem R, Cai X,. Genes regulated by androgen in the rat ventral prostate. Proc Natl Acad Sci USA 1997; 94: 12999-13004.
2. Xiao W, Zhang Q, Jiang F, Pins M, Kozlowski JM, Wang Z,. Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer. Cancer Res 2003; 63 (15): 4698-4704.
3. Xiao W, Zhang Q, Habermacher G, Yang X, Zhang AY, Cai X, et al. U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia. Oncogene 2008; 27 (11): 1536-1544.
4. Simone F, Luo RT, Polak PE, Kaberlein JJ, Thirman MJ,. ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties. Blood 2003; 101 (6): 2355-2362.
5. Luo RT, Lavau C, Du C, Simone F, Polak PE, Kawamata S, et al. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis. Mol Cell Biol 2001; 21 (16): 5678-5687.
6. Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD,. Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci USA 1994; 91 (25): 12110-12114.
7. Shilatifard A, Lane WS, Jackson KW, Conaway RC, Conaway JW,. An RNA polymerase II elongation factor encoded by the human ELL gene. Science 1996; 271 (5257): 1873-1876.
8. Liu M, Hsu J, Chan C, Li Z, Zhou Q,. The ubiquitin ligase Siah1 controls ELL2 stability and formation of super elongation complexes to modulate gene transcription. Mol Cell 2012; 46 (3): 325-334.
9. Simone F, Polak PE, Kaberlein JJ, Luo RT, Levitan DA, Thirman MJ,. EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein. Blood 2001; 98 (1): 201-209.
10. Kong SE, Banks CA, Shilatifard A, Conaway JW, Conaway RC,. ELL-associated factors 1 and 2 are positive regulators of RNA polymerase II elongation factor ELL. Proc Natl Acad Sci USA 2005; 102 (29): 10094-10098.
11. Wendler WM, Kremmer E, Forster R, Winnacker EL,. Identification of pirin, a novel highly conserved nuclear protein. J Biol Chem 1997; 272 (13): 8482-8489.
12. Pang H, Bartlam M, Zeng Q, Miyatake H, Hisano T, Miki K, et al. Crystal structure of human pirin: An iron-binding nuclear protein and transcription cofactor. J Biol Chem 2004; 279 (2): 1491-1498.
13. Dechend R, Hirano F, Lehmann K, Heissmeyer V, Ansieau S, Wulczyn FG, et al. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators. Oncogene 1999; 18 (22): 3316-3323.
14. Licciulli S, Luise C, Scafetta G, Capra M, Giardina G, Nuciforo P, et al. Pirin inhibits cellular senescence in melanocytic cells. Am J Pathol 2011; 178 (5): 2397-2406.
15. Licciulli S, Luise C, Zanardi A, Giorgetti L, Viale G, Lanfrancone L, et al. Pirin delocalization in melanoma progression identified by high content immuno-detection based approaches. BMC Cell Biol 2010; 11: 5.
16. Licciulli S, Cambiaghi V, Scafetta G, Gruszka AM, Alcalay M,. Pirin downregulation is a feature of AML and leads to impairment of terminal myeloid differentiation. Leukemia 2010; 24 (2): 429-437.
17. Jiang F, Ai J, Xiao W, Wang Z,. FB1, an E2A fusion partner in childhood leukemia, interacts with U19/EAF2 and inhibits its transcriptional activity. Cancer Lett 2007; 253 (2): 265-272.
18. Xiao W, Jiang F, Wang Z,. ELL binding regulates U19/Eaf2 intracellular localization, stability, and transactivation. Prostate 2006; 66 (1): 1-12.
19. Hahn J, Xiao W, Jiang F, Simone F, Thirman MJ, Wang Z,. Apoptosis induction and growth suppression by U19/Eaf2 is mediated through its ELL-binding domain. Prostate 2007; 67 (2): 146-153.